Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Aspira Women's Health Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +1 vs. Q3 2024
- Shares held
- 1.46M
- −897.4K (−38.1%) vs. Q3 2024
- Total value
- $1.03M
- −$879.4K (−46.1%) vs. Q3 2024
- New holders
- 4
- 4 more added
- Sold out
- 3
- 9 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AWHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $392 |
| Q2 2025 | 2 | $15.7K |
| Q1 2025 | 25 | $81.0K |
| Q4 2024 | 26 | $1.03M |
| Q3 2024 | 25 | $1.91M |
| Q2 2024 | 26 | $2.08M |
| Q1 2024 | 23 | $6.15M |
| Q4 2023 | 24 | $2.92M |
| Q3 2023 | 24 | $3.53M |
| Q2 2023 | 22 | $1.75M |
| Q1 2023 | 45 | $3.25M |
| Q4 2022 | 47 | $3.24M |
| Q3 2022 | 58 | $4.46M |
| Q2 2022 | 72 | $7.02M |
| Q1 2022 | 92 | $22.9M |
| Q4 2021 | 98 | $50.9M |
| Q3 2021 | 92 | $97.0M |
| Q2 2021 | 95 | $174.1M |
| Q1 2021 | 97 | $211.5M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Aspira Women's Health Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 710,000 | $500.6K | 0.01% | −546,000−43.5% | Reduced |
| Vanguard Group Inc | 274,089 | $193.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 98,108 | $69.2K | 0.00% | +8,209+9.1% | Added |
| BlackRock, Inc. | 82,767 | $58.4K | 0.00% | −735−0.9% | Reduced |
| Bank of America Corp | 58,307 | $41.1K | 0.00% | +5,313+10.0% | Added |
| Pine Valley Investments Ltd Liability Co | 33,400 | $23.5K | 0.00% | +2,200+7.1% | Added |
| Jane Street Group, LLC | 29,616 | $20.9K | 0.00% | +29,616 | New |
| Northern Trust Corp | 28,780 | $20.3K | 0.00% | −4,235−12.8% | Reduced |
| Northeast Financial Consultants Inc | 23,436 | $16.5K | 0.00% | 00.0% | Unchanged |
| Quantum Private Wealth, LLC | 21,799 | $15.4K | 0.00% | −21,592−49.8% | Reduced |
| Two Sigma Securities, LLC | 21,529 | $15.2K | 0.00% | −9,022−29.5% | Reduced |
| State Street Corp | 19,749 | $13.9K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 15,000 | $10.6K | 0.00% | 00.0% | Unchanged |
| M&T Bank Corp | 14,999 | $10.6K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 12,308 | $9.00K | 0.00% | −267−2.1% | Reduced |
| Tower Research Capital LLC (TRC) | 4,160 | $2.93K | 0.00% | −1,890−31.2% | Reduced |
| JPMorgan Chase & Co | 2,064 | $1.45K | 0.00% | −10.0% | Reduced |
| UBS Group AG | 2,045 | $1.44K | 0.00% | +200+10.8% | Added |
| Morgan Stanley | 1,616 | $1.14K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,499 | $1.06K | 0.00% | −6−0.4% | Reduced |
| Operose Advisors LLC | 1,000 | $705 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 610 | $430 | 0.00% | +610 | New |
| Group One Trading, L.P. | 119 | $84 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 21 | $15 | 0.00% | +21 | New |
| Global Wealth Strategies & Associates | 18 | $13 | 0.00% | +18 | New |
| Danske Bank A/S | 1 | $1 | 0.00% | 00.0% | Unchanged |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −316,294−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −27,547−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |